Pharmacokinetics and drug interactions of Lurasidone in rats
碩士 === 國立成功大學 === 臨床藥學與藥物科技研究所 === 105 === INTRODUCTION Lurasidone is a novel atypical antipsychotic drug that was recently approved for the treatment of schizophrenia and bipolar depression by the the Food and Drug Administration of United States. Lurasidone has potent blocking activities for the d...
Main Authors: | Kuang-YuHsieh, 謝光俞 |
---|---|
Other Authors: | Chen-His Chou |
Format: | Others |
Language: | zh-TW |
Published: |
2017
|
Online Access: | http://ndltd.ncl.edu.tw/handle/pq5w5p |
Similar Items
-
Lurasidone hydrochloride
by: Huijuan Jiang, et al.
Published: (2012-05-01) -
Lurasidone Induced Thrombocytopenia: Is it a Signal of Drug Induced Myelosuppression?
by: Mohammad Rafi, et al.
Published: (2018-03-01) -
Lurasidone-induced oculogyric crisis
by: Soumitra Das, et al.
Published: (2017-01-01) -
Lurasidone-induced parkinsonism and hyperprolactinemia
by: Navratan Suthar, et al.
Published: (2019-01-01) -
Antipsychotic treatments; Focus on lurasidone
by: Tomiki eSumiyoshi
Published: (2013-08-01)